Background: 4-10% of the general population and 20% of primary care patients have what are called "non-specific, functional, and somatoform bodily complaints." These often take a chronic course, markedly impair the sufferers' quality of life, and give rise to high costs. They can be made worse by inappropriate behavior on the physician's part.
W hen the S2e guideline "Somatoform disorders" (1) expired, the German College of Psychosomatic Medicine (DKPM, Deutsches Kollegium für Psychosomatische Medizin) and the German Society of Psychosomatic Medicine and Medical Psychotherapy (DGPM, Deutsche Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie) determined to rework it comprehensively in an interdisciplinary way for the new edition. Under the coordination of these bodies, from 2008 to 2012, representatives of 28 medical and psychological specialist societies, the German Association for the Support of Self Help Groups (patient representative), and the Association of Scientific Medical Societies in Germany (AWMF, Arbeitsgemeinschaft medizinischer Fachgesellschaften) (eBox 1) developed the new S3 guideline "Management of patients with non-specific, functional, and somatoform bodily complaints" (NFS), of which the present article is the official short version (2) (3) (4) .
Method
The guideline group included members from all areas of care and was balanced in terms of gender and seniority. At the inaugural meeting, key questions on all clinically relevant themes were formulated and divided up between nine working groups. Building on the 2002 S2e guideline, a seven-member steering group (eBox 1) carried out a systematic literature search of publications dating from 1 January 2000 to 1 January 2009 (for search terms see eBox 2), which was added to and brought up to date by the working groups up to May 2011 (3) . After assessment of inclusion and exclusion criteria (eBox 3) and the quality and relevance of the studies (e1) (eTable 1), 761 publications were included for the guideline (Figure 1) . The working groups analyzed the literature, evaluated the evidence levels (ELs) (e2) (eTable 2), and developed 148 recommendations, statements, and source texts. For the most important forms of therapy, examples of numbers needed to treat (NNTs) were calculated as a statistical measure of efficacy ( Table 1) . The guideline was modified in two online Delphi procedures and three consensus conferences, and finalized by consensus, in most cases strong consensus (e3) (eTable 3). The corresponding recommendation grades (RGs) were based on the evidence levels, but could be raised or lowered during the consensus procedure (e4) (eFigure). Recommendations units or practices, a percentage up to 50% may be assumed (2, 4, e25) . In the general population, 10% of those affected with an FSS also fulfill the criteria of one or more other FSSs; in clinical populations this overlap may be as much as 50% (e8, e9, e26) (EL 2a) . In both clinical and population-based samples, NFS show a comorbidity that increases with the severity of the NFS, including depressive, anxiety (11, e27, e28) , and posttraumatic stress disorders (e29) as well as addiction disorders (medications, alcohol) (e30, e31) . In severe cases (full-blown somatization disorder F45.0) there are often co-morbid personality disorders (e32, e33) (EL 2a). A majority show high, dysfunctional use of the health care system, especially in cases of psychological co-morbidity (9, e34) (EL 2b) . The result is high direct (multiple diagnoses, overdiagnosis, inappropriate treatment) and indirect health costs (loss of productivity, long-term inability to work, early retirement) (13, e35) . Also in older patients, NFS parts of the complaints should be considered, even if the differential diagnosis is more complex and uncertain because of multimorbidity and multimedication. (14, e36) 
(EL 2a, RG B).

Course and prognosis
Life expectancy for patients with NFS is presumably normal (e37, e38) , but quality of life is more impaired than with somatic diseases (e39) (EL 2b). Suicide risk, especially among those in chronic pain, is greater than in the general population (e40, e41) . In patients with fibromyalgia, the standardized mortality ratio for suicide was between 3.3 (95% confidence interval [95% CI] 2.2-5.1) (Danish retrospective cohort Effectiveness of selected therapies in comparison to control groups (at the end of therapy) in patients with non-specific, functional, and somatoform bodily complaints; based on systematic review articles with meta-analyses of randomized controlled studies (2, 4) NFS, non-specific, functional, and somatoform bodily complaints; SDM, standard deviation of the mean (therapy group versus control group at the end of therapy); RR, relative risk (therapy group versus control group at the end of therapy); NNT, number needed to treat; 95% CI, 95% confidence interval; MUS, medically unexplained symptoms; CBT, cognitive behavioral therapy; SNRI, selective serotonin and norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor * 1 NNTs were calculated using the Wells Calculator Software of the Cochrane Musculoskeletal Group Editorial Office. A half standard deviation was chosen as the minimally important difference (MID) (e101).
NFS
MUS and somatoform disorders
Fibromyalgia syndrome study, n = 1269 women [e38] ) and 10.5 (95% CI 4.5-20.7) (US retrospective case control study, n = 8186 [e37] ). Irrespective of clinical setting, a less severe course with improvement of functioning and quality of life is seen in 50% to 75% of those affected, and a more severe course (usually marked functional/ somatoform disorders, with deterioration of functioning and quality of life is seen in 10% to 30% (15) (EL 1b).
Principles and preconditions of diagnosis and treatment
Attitude and physician-patient relationship Since the physician-patient relationship is often felt to be difficult on both sides (e42-e45) , building up a sound working alliance on a partnership basis is of central importance (7, e46-e48) . An active, supportive and biopsychosocial attitude ("as well/as attitude") is recommended, focusing on symptoms and on coping with them. It is characterized by situational consistency; that is the right balance between reticence and authenticity ("I'm not going to say everything that would be authentic, but what I do say should be authentic") (e52) (RB B).
Communication skills
First, the physician should allow the patient to describe the complaints spontaneously and explicitly ("accepting the complaint") (e53) (EL 4, EG B), signaling attention, interest, and acceptance in both verbal and nonverbal ways ("active listening") (EL 4, EG B). Psychosocial themes should be handled casually and indirectly rather than by confronting them, e.g., by accompanying the patient's report switching to and fro between hinting at psychosocial stressors and returning to the complaints description ("tangential conversation") (e51). Clues to psychosocial problems and
Iatrogenic chronification factors/unfavorable physician behavior (e14-e21) (CCP)
• Attitude and preconditions of treatment -One-sided biomedical or psychologizing approach ("either/or" model) -Lack of cooperation between treating health professionals
• Diagnostic investigations
-Overdiagnosis and multiple organic diagnostic investigations as pure exclusion diagnostics -Overestimation of non-specific somatic findings -Insufficient consideration of psychosocial factors and mental co-morbidity -Failure to take (adequately) into account social medical aspects (invalidity benefit, desire for pension) aand other relieving aspects of the "sick role" (secondary gain from being ill)
• Communication skills -Presenting findings in a way that causes anxiety; giving "catastrophizing" medical advice -Failure to give any diagnosis ("there's nothing wrong with you") or giving a stigmatizing diagnosis ("it's all in the mind") -Giving poor information about the clinical picture without adequately explaining the patient's complaints -Not involving the patient sufficiently (his or her ideas about causes and goals)
• Treatment planning -Unstructured proceeding with complaint-led or even emergency appointments -Insufficient treatment planning without setting therapy goals together with the patient
• Treatment -Promoting passive therapeutic approaches (e.g., passive physical procedures, injections, operations) -Preferring and inappropriately prescribing invasive or addiction-promoting therapies -Writing patients off sick for long periods without careful consideration -Not referring patients to psychosocial care, or referring them late, or with inadequate preparation and/or follow-up of the referral -Failing to initiate multimodal therapy that may be indicated
• Medication
-Prescribing drugs without taking stock of whatever medications the patient may already be taking -Insufficient analgesic treatment for actue pain -Pain-contingent use of drugs "as needed" (especially analgesics) -Unreflecting prescription of addictive drugs, especially opioids and benzodiazepines -Non-indicated prescription of neuroleptics, e.g., "as a weekly/restaurative injection" -Prescribing long-term psychopharmacotherapy as a monotherapy without appropriate psychotherapy needs shall be picked up empathetically and spoken of as meaningful (e54) (EL 1b, RG A). In constructing the contextual interdependencies, phrases from the vernacular can help ("Is something making you heavy hearted?") (EL 5, RG 0). The patient should be offered to make a joint decision together with the physician once enough information has been given ("shared decision making") (e55) (EL 2b, RG A).
Simultaneous biopsychosocial diagnostic assessment
For early diagnosis of NFS, stepped simultaneous diagnostic assessment of both somatic and psychosocial conditioning factors should be carried out. If necessary further medical and/or psychotherapeutic specialists should be consulted (e56-e58) (EL 1b, RG A) ( Figure 2 ). For patients with a chronic course, the first thing is to take stock of the results of previous diagnostic and therapeutic procedures (EL 5, RG 0). Waiting for the exclusion of somatic disease despite the presence of psychosocial stressors is contraindicated.
Biopsychosocial history taking
First, the bodily complaints should be recorded precisely (nature, location, number, frequency, duration, intensity) (e53) (EL 3b, RG B). Because accompanying complaints are often not reported spontaneously, history taking should be extended beyond the main symptoms, e.g., by systematic questioning about the different organ systems (2, 4) (EL 2b, RG A). The number of symptoms is an important predictor of the presence of NFS and of an unfavorable course (15) (EL 1b). For all bodily complaints, everyday functioning and psychological state should be assessed even at the first consultation (e59) (EL 2b, RG B). The patient's subjective theory of the illness and illness/health behavior should be explored, including, if there are cues about psychosocial stressors or functional impairment, the context of the complaints (family, social network, work, biographical stressors, and resources) (CCP).
Somatic diagnostic investigations
Basic organic diagnostic investigation including physical examination is always necessary. Depending on the pattern of symptoms, specialist diagnostic procedures may also be required (e58) (EL 5, RG B). In the absence of "red flags" and so long as any dangerous illness appears unlikely, a "watchful waiting" approach is recommended, which will not increase the patient's anxiety (e60) (EL 1b, RG B). Any tests should be discussed with the patient before and after they are carried out in a "de-catastrophizing" way ("normal results
TABLE 2
Guide to green, yellow, and red flags and clinical characteristics of severe courses (modified from 7, e62, e63)
Possible protective/prognostically favorable factors (green flags)
• Active coping strategies (e.g., physical exercise, positive attitude, motivation for psychotherapy)
• Healthy life style (enough sleep, balanced diet, exercise and relaxation)
• Secure relationships, social support
• Good work conditions
• Sustainable physician-patient relationship
• Biopsychosocial, decatastrophizing approach, avoiding unnecessary investigations and treatments
• Health care system that is freely accessible but emphasizes selfresponsibility and prevention
Clinical characteristics of more severe courses (yellow flags)
• Several complaints (polysymptomatic course)
• Frequent or persistent complaints (complaint-free intervals non-existent or rare or brief)
• Dysfunctional perception of health/ illness (e.g., catastrophizing thoughts, substantial health-related anxiety)
• Dysfunctional health/illness behavior (high use of health services, resting and avoidance behavior)
• Markedly reduced ability to function; inability to work > 4 weeks, social withdrawal, physical deconditioning, possibly with physical sequelae
• Moderate to severe psychosocial stress (possibly biographical stressors) (e.g., low spirits, anxiety about the future, few social contacts)
• Psychological co-morbidity (especially depression, anxiety, post-traumatic stress disorder, substance dependence disorders, personality disorders)
• Physician-patient relationship experienced (by both) as "difficult"
• Iatrogenic "somatizing" factors (Box 1)
Warning signs of preventable severe courses (red flags)
• Very severe complaints
• Occurrence of known warning signs of a somatically defined disease
• Indications of serious self-harming behavior
• Suicidality
• Physical sequelae (e.g., faulty posture becomes fixed, limitation of movement up to severe restricted mobility of spared joints, contractures, serious weight gain, patient stays in bed)
• Particularly severe psychological co-morbidity (e.g., development of severe depression; anxiety that keeps the patient confined in the home)
• Frequent change of treating phyisicans and therapists and frequent discontinuation of therapy
• Indications of severe iatrogenic dam aging behavior expected") and the reasons for doing them clearly explained (transparency) (e61). A reasonable endpoint for the somatic diagnostic pathway should be agreed and adhered to (EL 1b, RG A).
Severity assessment
Characteristics of more severe cases ("yellow flags") and red flags for more severe, complicated courses including suicidality should be repeatedly evaluated (7, e62, e63 ) (EL 2b, RG B). Some protective factors ("green flags") presumably have a favorable effect on the prognosis (e64) (EL 4) and should be recorded and supported (RG B) ( Table 2 ).
Treatment
Treatment should adhere to a severity-staged, collaborative and coordinated model of care (7, 16, 17, e65) (RG A) (Box 2, Figure 3 ).
Basic treatment in primary care and specialist somatic medicine The basis of treatment should be "Basic Psychosomatic Care" (CCP). Both complaints and findings should be explained clearly and reassuringly, and psychophysiological relationships should be explained (psychoeducation: e.g., vicious circles of resting, somatosensory amplification etc.) (17, e66) (EL 2a). This should connect with the patient's subjective theory of the illness, so that a biospychosocial explanatory model can be built up (RG B). The physician should offer a positive description of the complaints (e.g., "non-specific," "functional," "bodily distress," with a corresponding diagnosis if appropriate), but should not belittle ("There's nothing wrong with you,") or use stigmatizing terms ("hysteria") (e66, e67) (EL 2b, RG B). Important elements are reassuring the patient that dangerous disease is unlikely (17, e56, e60 ) (EL 2b, RGA) and no unnecessary steps should be taken ("first, do no harm", "quaternary prevention") (e68) (EL 5, RG B), and furthermore long-term support with physical and social activation (7, e69, e70 ) (EL 2b). Medication (e.g., symptomatic medication for patients with irritable bowel syndrome, pain alleviation, treatment of psychological co-morbidity) should be discussed with the aim of alleviating symptoms within the framework of an overall treatment plan, carefully weighing the risks and benefits, and for a limited period (4) (CCP). Physicians should not be too quick to certify patients as unable to work, and should weigh the advantages (rest, relief from stress) against the disadvantages (avoidance, increased weakness due to rest, loss of participatory activity) early on (e83) (EL 4-5). Short-term sick notes (7 days, patient to attend again, another 7 days if appropriate) may be considered, in order to support spontaneous improvement of symptoms and promote the therapeutic relationship and/or adherence to treatment (RG B). Psychotherapy may be considered, e.g., if the patient wants to discuss psychosocial stressors or when the bodily complaints are incidental findings in, for example, a patient with depression (CCP).
Additional steps in severe courses
Even in severe courses, care at the primary level and specialist somatic medical level is at the center of management. Within the framework of a clear treatment plan, there should be a stronger structuring of the framework and content of treatment (e71) (EL 2a, RG B). Essential elements are regular appointments that are time-limited and are not complaint-led (e48, e71) (EL 2b) along with treatment of comorbid disorders in accordance with guidelines (RG B). Specific, realistic therapy goals should be developed with the patient (18, e72) (EL 2b, RG A), in the process of which the importance of self-responsibility and collaboration should be conveyed (EL 4). Physical activation (especially
Stepped, collaborative, and coordinated care model
-Patients with less severe courses should if possible be cared for by their primary care physician (21, e96) (EL 2b, RG B).
-Patients with more severe courses should be referred for early psychotherapeutic assessment and, if appropriate, concurrent psychotherapy (7, 22-24, e80 ) (EL 1a, RG A). -Patients with particularly severe courses require a multimodal therapeutic approach, i.e., interdisciplinary treatment including at least two specialties, one of them psychosomatic, psychological, or psychiatric, following a fixed treatment plan led by a qualified physician; because of lack of outpatient facilities, this often requires treatment to be on an inpatient or day clinic basis (for indications see Box 3) (CCP).
• Collaborative: Close collaboration between all contributing physicians and therapists is important, ideally within the framework of a mutually agreed treatment approach, which may be multimodal (e97) (EL 1b).
• Coordinated: The collaborative care should be coordinated by the primary care physician following a structured overall care plan (e71) (EL 1b, RG B). Stepped, collaborative, and coordinated care model according to severity level (modified from 2, 4) aerobic exercise [endurance training] and strength training of low to moderate intensity) should be carried out in stages, with slowly increasing work alternating with rest (7, e73-e76) (EL 2b, RG A) ( Table 2 ) and should be accompanied by sustained encouragement. Similarly, the patient should be encouraged towards social activation (7, e69, e70) . Some body-centered or nonverbal therapy elements and relaxation techniques (e.g., biofeedback, progressive muscle relaxation, autogenic training, tai chi, qi-gong, yoga, Feldenkrais, mindfulness training, meditation, writing as therapy, music therapy) may be recommended as additional elements within an overall treatment plan, but not as monotherapies (e77-e79) (EL 2a). In severe cases where pain predominates, low-dose, short-term antidepressant treatment should be given (7, 19, e80-e82) (EL 1a, RG A) ( Table 1 ). In severe courses where pain does not dominate, treatment with antidepressants according to guidelines should be given only where there is relevant psychological co-morbidity (e5) (EL 2a, RG B). Referrals, especially psychosocial referrals, should be well organized and carefully discussed both before and after they take place (CCP).
Non
Psychosocial co-assessment
Requesting a specialist psychosocial assessment will reduce health service utilization (20) (EL 1a, RG A). A consultation/care recommendation letter provided to the primary care physician (information about the patient's illness and specific recommendations for treatment including assessment wether inpatient or day clinic treatment is indicated [Box 3]), which may if necessary be repeated, leads to improvement in the level of functioning and saves costs when used as an additional measure, but not on its own (21, 22) 
(EL 1a, RG A).
Disorder-oriented psychotherapy
In severe courses, psychotherapeutic interventions should be disorder-/ or symptom-oriented-focused, context-related (co-morbidity, social situation, ability to work), and resource-oriented (CCP). Wider evidence is available for various NFS -with low to moderate effect sizes -especially for cognitive behavioral therapy (22-24, e80, e81, e84, e85) (EL 1a), and also for psychodynamic (interpersonal) (7, 25, e81, e86) (EL 1b) and hypnotherapeutic/imaginative approaches (e81, e85, e87, e88) (EL 1a, RG A) ( Table 1) . Followup studies showing positive effects are available for psychotherapy and physical activation, but not for medications (e74, e75, e81, e89) .
Particularly severe courses: multimodal treatment, if necessary on an inpatient/day clinic basis
In particularly severe and chronic cases, multimodal treatment should already be initiated at the primary care and specialist somatic medical level (Box 2). Multimodal treatment has been shown to be effective especially for chronic pain syndrome (e90) (EL 1b, CCP). It should be assessed wether inpatient/day clinic treatment at a facility offering multimodal therapy at a clinic offering multimodal therapy is indicated, including when there are few or no options for treatment on an outpatient basis (Box 3) (e91, e92) (CCP).
Rehabilitation
Rehabilitation should also follow a multimodal approach (e93). The main goals are improvement in ability to function and to work, and to prevent (further) chronification. The sociomedical baseline situation (e.g. duration of inability to work) appears essential for success (e94) (CCP). In suitable facilities (e.g., day clinics with the appropriate range of indications/treatments), rehabilitation measures should be done at first on an outpatient basis, in close collaboration between primary care physician/somatic medical specialist and psychotherapist, and only after that on an inpatient or partly inpatient basis.
Reassessment after 3 months at the latest
To prevent cases become dangerous or chronic when this could have been prevented, complaints, diagnostic categorization, and the severity of illness and the outcome of treatment should be reassessed after 3 months at the latest (e56, e95) (EL 2b, RG B). If appropriate, and in agreement with the patient and collaborating physicians and therapists, both somatic and psychosocial diagnostic investigations and treatment should be adjusted. Basic medical diagnostic investigations including physical examination should be regularly repeated, especially where complaints persist. In this way, changes in symptoms will be recognized, organic disease will be identified, the patient will be given a feeling of being looked after and taken seriously, and unnecessary tests will be avoided (EL 5, RG B). After 6 months, if treatment on an outpatient basis fails, treatment on an inpatient or day clinic basis should be considered (Box 3).
Discussion
In the S3 guideline "Management of patients with nonspecific, functional, and somatoform bodily complaints," a broad group of medical and psychological societies together with a patient representative have for the first time achieved an evidence-based consensus on terminology and care of these patients that is interdisciplinary and bridges the borders of health care sectors as well as psychosocial and somatic disciplines. The innovations are summarized in Box 4. To date, randomized controlled studies, reviews, and meta-analyses are available on only a few aspects (Figure 1) , so that in places the present guideline has to rely on weaker evidence or clinical consensus. Overall, a very strong need is evident for fundamental research as well as research in treatment and health services. Guideline texts and practice materials may be downloaded from the AWMF website (www.awmf.org/ leitlinien/detail/ll/ 051-001.html) and from the project website (www. funktionell.net). An important complement to this guideline is the Evidence-Based Guideline on Psychotherapy of Somatoform Disorders and Associated Syndromes by the Group for Clinical Psychology and Psychotherapy of the German Society of Psychology (24) . This is primarily aimed at psychotherapists as an aid to choosing effective psychotherapeutic interventions. BOX 4 What is new in comparison to the S2e guideline "Somatoform disorders"?
• Consensus between 29 medical and psychological specialist societies and one patient representative that bridges the usual divisions between the psychosocial and the somatic disciplines and between the various levels of care
• As a meta-guideline using the triple term "non-specific, functional, and somatoform bodily complaints, the new guideline emphasizes the common elements in managing the multifarious manifestations of burdensome bodily complaints in a symptom-focused, comprehensive way 
Methodological quality
Bias can be largely ruled out or cannot be identified
Bias can be largely ruled out, slight errors may exist in some areas or cannot be assessed Identifiable but not serious bias present in some areas Slight bias identified in several areas, or some areas cannot be assessed with sufficient certainty because of inadequate description
More than slight bias identified in several areas, or such bias cannot be ruled out with sufficient certainty because of inadequate description
Influence on validity of study results
Low risk of bias; any bias will have at most a small effect on study results
Uncertain risk of bias; study results may be affected Risk of bias; study results probably affected High risk of bias; an effect on study results must be assumed eTABLE 2
Evidence levels (EL) according to the Oxford Centre for Evidence-Based Medicine (e2) * 1 "absolute SpPin," test specificity is so high that a positive result rules the diagnosis in with certainty; "absolute SnNout," test sensitivity is so high that a positive result rules the diagnosis out * 2 Dramatic effects: this is the case if all patients died before the treatment was available, but after the introduction of the treatment some patients survive; or if some patients died before the treatment was available, but after introduction of the treatment no patient dies 
